Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.85 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.85 |
| ▸ | CYP4Z1 | Q86W10 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.54 |
| ▸ | CYP4F11 | Q9HBI6 | 1/20 | 0.53 |
| ▸ | CYP4F12 | Q9HCS2 | 1/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.49 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.49 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL363982 | 0.94 | CYP4F2 (0.77) | CYP4F2CYP4A11CYP4Z1TDP1HRH3 | |
| SCHEMBL11437256 | 0.94 | CYP4F2 (0.77) | CYP4F2CYP4A11CYP4Z1TDP1HRH3 | |
| SCHEMBL879130 | 0.94 | CYP4F2 (0.77) | CYP4F2CYP4A11CYP4Z1TDP1HRH3 | |
| SCHEMBL10206072 | 0.94 | CYP4F2 (0.77) | CYP4F2CYP4A11CYP4Z1TDP1HRH3 | |
| SCHEMBL304455 | 0.92 | CYP4F2 (0.74) | CYP4F2CYP4A11CYP4Z1TDP1HRH3 | |
| SCHEMBL22098222 | 0.92 | CYP4F2 (1.00) | CYP4F2CYP4A11CYP4Z1TDP1HRH3 | |
| SCHEMBL5543917 | 0.92 | CYP4F2 (0.74) | CYP4F2CYP4A11CYP4Z1TDP1HRH3 | |
| SCHEMBL4889211 | 0.92 | CYP4F2 (0.80) | CYP4F2CYP4A11CYP4Z1TDP1HRH3 | |
| SCHEMBL1587300 | 0.92 | CYP4F2 (0.74) | CYP4F2CYP4A11CYP4Z1TDP1HRH3 | |
| SCHEMBL11322023 | 0.92 | CYP4F2 (0.74) | CYP4F2CYP4A11CYP4Z1TDP1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3383796-B1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2020-09-16 | — | — | EP | disclosed |
| US-10597300-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2019-07-18 | — | — | US | disclosed |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2019-07-18 | — | — | US | disclosed |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-04-09 | — | — | US | disclosed |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-04-09 | — | — | US | disclosed |
| EP-3383796-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | Exxonmobil Research And Engineering Company (US) | 2018-10-10 | — | — | EP | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| WO-2017095705-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2017-06-08 | — | — | WO | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| EP-2479203-A1 | AROMATIC POLYESTER | Muroran Institute of Technology (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120172570-A1 | AROMATIC POLYESTER | NITTA CORPORATION | 2012-07-05 | — | — | US | disclosed |
| US-8129493-B2 | Aromatic polyester | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20110092662-A1 | AROMATIC POLYESTER | NITTA CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-5093370-A | Useful prior to insertion of tracheotomy tube or discission | TOBISHI YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1992-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | F12, PHAX, WDR82 | CYP4F2 2876/4885CYP4A11 1392/4885CYP4Z1 799/4885 |
| US-10597300-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | CD14, ERG28, DAP3 | CYP4F2 2148/4885CYP4A11 3171/4885CYP4Z1 2079/4885 |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | CD14, ERG28, DAP3 | CYP4F2 2148/4885CYP4A11 3171/4885CYP4Z1 2079/4885 |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | CYP4F2 2148/4885CYP4A11 3171/4885CYP4Z1 2079/4885 |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | CYP4F2 2148/4885CYP4A11 3171/4885CYP4Z1 2079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.